Peter Rahmer, See remarks at Relay Therapeutics, Inc. (RLAY), sold 59,664 shares at $7.50 ($439K) on 2025-10-29, disclosed to the SEC on 2025-10-30.
Open-market sale of $439k RLAY by See remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.29 | 19,135 | $139K | 31.7% |
| 2 | $7.29 | 19,135 | $139K | 31.7% |
| 3 | $7.50 | 21,394 | $160K | 36.5% |
| Total | $7.37 avg | 59,664 | $439K | 100% |
| Filing → |
| RLAY | SELL | 2026-07-02 | $955K | — | Filing → |
| RLAY | SELL | 2026-04-30 | $11K | — | Filing → |
| RLAY | SELL | 2026-01-29 | $100K | — | Filing → |